BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anstey NM, Douglas NM, Poespoprodjo JR, Price RN. Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol 2012;80:151-201. [PMID: 23199488 DOI: 10.1016/B978-0-12-397900-1.00003-7] [Cited by in Crossref: 145] [Cited by in F6Publishing: 112] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Drysdale M, Tan L, Martin A, Fuhrer IB, Duparc S, Sharma H. Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review. Infect Dis Ther 2023;12:33-51. [PMID: 36378465 DOI: 10.1007/s40121-022-00713-w] [Reference Citation Analysis]
2 Olvany JM, Williams SM, Zimmerman PA. Global perspectives on CYP2D6 associations with primaquine metabolism and Plasmodium vivax radical cure. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.752314] [Reference Citation Analysis]
3 White NJ. Severe malaria. Malar J 2022;21:284. [PMID: 36203155 DOI: 10.1186/s12936-022-04301-8] [Reference Citation Analysis]
4 K. B. F, Bola O O, O. T O, A. O O. ANTIBIOTIC RESISTANCE AND PLASMID ANALYSIS OF BACTERIA ISOLATED FROM CHILDREN WITH BACTEREMIA AND MALARIA IN EKITI STATE. ijsr 2022. [DOI: 10.36106/ijsr/7225445] [Reference Citation Analysis]
5 Trivedi S, Chakravarty A. Neurological Complications of Malaria. Curr Neurol Neurosci Rep 2022. [PMID: 35699901 DOI: 10.1007/s11910-022-01214-6] [Reference Citation Analysis]
6 Zhang H, Shen F, Yu J, Ge J, Sun Y, Fu H, Cheng Y. Plasmodium vivax Protein PvTRAg23 Triggers Spleen Fibroblasts for Inflammatory Profile and Reduces Type I Collagen Secretion via NF-κBp65 Pathway. Front Immunol 2022;13:877122. [DOI: 10.3389/fimmu.2022.877122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Baird JK. African Plasmodium vivax malaria improbably rare or benign. Trends Parasitol 2022:S1471-4922(22)00109-X. [PMID: 35667992 DOI: 10.1016/j.pt.2022.05.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Cardona-arias JA, Carmona-fonseca J. Congenital malaria: Frequency and epidemiology in Colombia, 2009-2020. PLoS ONE 2022;17:e0263451. [DOI: 10.1371/journal.pone.0263451] [Reference Citation Analysis]
9 Fernández D, Segura C, Arman M, McGill S, Burchmore R, Lopera-Mesa T. Uncomplicated Plasmodium vivax malaria: mapping the proteome from circulating platelets. Clin Proteomics 2022;19:1. [PMID: 34991449 DOI: 10.1186/s12014-021-09337-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Phyo AP, Dahal P, Mayxay M, Ashley EA. Clinical impact of vivax malaria: A collection review. PLoS Med 2022;19:e1003890. [PMID: 35041650 DOI: 10.1371/journal.pmed.1003890] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
11 Ketema T, Bacha K, Getahun K, Bassat Q. In vivo efficacy of anti-malarial drugs against clinical Plasmodium vivax malaria in Ethiopia: a systematic review and meta-analysis. Malar J 2021;20:483. [PMID: 34952581 DOI: 10.1186/s12936-021-04016-2] [Reference Citation Analysis]
12 Nateghpour M, Etemadi S, Motevalli Haghi A, Eslami H, Mohebali M, Farivar L. Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients. Eur J Med Res 2021;26:134. [PMID: 34823591 DOI: 10.1186/s40001-021-00607-6] [Reference Citation Analysis]
13 Budi Setia Asih P, Syafruddin D. Plasmodium vivax and Drug Resistance. Plasmodium Species and Drug Resistance 2021. [DOI: 10.5772/intechopen.97320] [Reference Citation Analysis]
14 Cui L, Brashear A, Menezes L, Adams J. Elimination of Plasmodium vivax Malaria: Problems and Solutions. Current Topics and Emerging Issues in Malaria Elimination 2021. [DOI: 10.5772/intechopen.96604] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Satyagraha AW, Sadhewa A, Panggalo LV, Subekti D, Elyazar I, Soebianto S, Mahpud N, Harahap AR, Baird JK. Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria. PLoS Negl Trop Dis 2021;15:e0009610. [PMID: 34270547 DOI: 10.1371/journal.pntd.0009610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Raissi V, Etemadi S, Getso MI, Mehravaran A, Raiesi O. Structure-genetic diversity and recombinant protein of circumsporozoite protein (CSP) of vivax malaria antigen: A potential malaria vaccine candidate. Gene Reports 2021;23:101132. [DOI: 10.1016/j.genrep.2021.101132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Tsapi MT, Kornobis E, Puchot N, English S, Proux C, Goupeyou-youmsi J, Sakuntabhai A, Marie-agnes-dillies, Milijaona R, Girod R, Ndiath MO, Bourgouin C. Differential transcriptomic response of Anopheles arabiensis to Plasmodium vivax and Plasmodium falciparum infection.. [DOI: 10.1101/2021.05.28.446219] [Reference Citation Analysis]
18 Kho S, Qotrunnada L, Leonardo L, Andries B, Wardani PAI, Fricot A, Henry B, Hardy D, Margyaningsih NI, Apriyanti D, Puspitasari AM, Prayoga P, Trianty L, Kenangalem E, Chretien F, Brousse V, Safeukui I, Del Portillo HA, Fernandez-Becerra C, Meibalan E, Marti M, Price RN, Woodberry T, Ndour PA, Russell BM, Yeo TW, Minigo G, Noviyanti R, Poespoprodjo JR, Siregar NC, Buffet PA, Anstey NM. Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy study. PLoS Med 2021;18:e1003632. [PMID: 34038413 DOI: 10.1371/journal.pmed.1003632] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 23.0] [Reference Citation Analysis]
19 Auburn S, Cheng Q, Marfurt J, Price RN. The changing epidemiology of Plasmodium vivax: Insights from conventional and novel surveillance tools. PLoS Med 2021;18:e1003560. [PMID: 33891580 DOI: 10.1371/journal.pmed.1003560] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
20 White NJ. Anti-malarial drug effects on parasite dynamics in vivax malaria. Malar J 2021;20:161. [PMID: 33743731 DOI: 10.1186/s12936-021-03700-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
21 Santos MLS, Coimbra RS, Sousa TN, Guimarães LFF, Gomes MS, Amaral LR, Pereira DB, Fontes CJF, Hawwari I, Franklin BS, Carvalho LH. The Interface Between Inflammatory Mediators and MicroRNAs in Plasmodium vivax Severe Thrombocytopenia. Front Cell Infect Microbiol 2021;11:631333. [PMID: 33791239 DOI: 10.3389/fcimb.2021.631333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Clark MA, Kanjee U, Rangel GW, Chery L, Mascarenhas A, Gomes E, Rathod PK, Brugnara C, Ferreira MU, Duraisingh MT. Plasmodium vivax infection compromises reticulocyte stability. Nat Commun 2021;12:1629. [PMID: 33712609 DOI: 10.1038/s41467-021-21886-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
23 Bellazreg F, Slama D, Lasfar NB, Abid M, Zaghouani H, Rouis S, Hachfi W, Letaief A. Neurological manifestations following cured malaria: don't forget post-malaria neurological syndrome. Afr Health Sci 2021;21:273-6. [PMID: 34394307 DOI: 10.4314/ahs.v21i1.35] [Reference Citation Analysis]
24 Rosado J, White MT, Longley RJ, Lacerda M, Monteiro W, Brewster J, Sattabongkot J, Guzman-Guzman M, Llanos-Cuentas A, Vinetz JM, Gamboa D, Mueller I. Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts. PLoS Negl Trop Dis 2021;15:e0009165. [PMID: 33591976 DOI: 10.1371/journal.pntd.0009165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
25 Walloch P, Hansen C, Priegann T, Schade D, Beitz E. Pentafluoro-3-hydroxy-pent-2-en-1-ones Potently Inhibit FNT-Type Lactate Transporters from all Five Human-Pathogenic Plasmodium Species. ChemMedChem 2021;16:1283-9. [PMID: 33336890 DOI: 10.1002/cmdc.202000952] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
26 He X, Xia L, Tumas KC, Wu J, Su XZ. Type I Interferons and Malaria: A Double-Edge Sword Against a Complex Parasitic Disease. Front Cell Infect Microbiol 2020;10:594621. [PMID: 33344264 DOI: 10.3389/fcimb.2020.594621] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
27 Castaldo N, Tascini C, Della Siega P, Peghin M, Pecori D. Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature. Malar J 2020;19:419. [PMID: 33228672 DOI: 10.1186/s12936-020-03476-2] [Reference Citation Analysis]
28 Matlani M, Kojom LP, Mishra N, Dogra V, Singh V. Severe vivax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India. Ann Clin Microbiol Antimicrob 2020;19:49. [PMID: 33126884 DOI: 10.1186/s12941-020-00393-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
29 Tadesse G, Kamaliddin C, Doolan C, Amarasekara R, Legese R, Mohon AN, Cheaveau J, Yewhalaw D, Pillai DR. Active case detection of malaria in pregnancy using loop-mediated amplification (LAMP): a pilot outcomes study in South West Ethiopia. Malar J 2020;19:305. [PMID: 32854715 DOI: 10.1186/s12936-020-03380-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
30 Santos MLS, Coimbra RS, Sousa TN, Guimarães LFF, Gomes MS, Amaral LR, Pereira DB, Fontes CJF, Hawwari I, Franklin BS, Carvalho LH. A distinct fingerprint of inflammatory mediators and miRNAs in Plasmodium vivax severe thrombocytopenia.. [DOI: 10.1101/2020.08.20.260463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Rosado J, White MT, Longley RJ, Lacerda M, Monteiro W, Brewster J, Sattabongkot J, Guzman-guzman M, Llanos-cuentas A, Vinetz JM, Gamboa D, Mueller I. Heterogeneity in response to serological exposure markers of recentPlasmodium vivaxinfections in contrasting epidemiological contexts.. [DOI: 10.1101/2020.07.01.20143503] [Reference Citation Analysis]
32 Silva AR, Moraes BPT, Gonçalves-de-Albuquerque CF. Mediterranean Diet: Lipids, Inflammation, and Malaria Infection. Int J Mol Sci 2020;21:E4489. [PMID: 32599864 DOI: 10.3390/ijms21124489] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
33 Padilla-Rodríguez JC, Olivera MJ, Guevara-García BD. Parasite density in severe malaria in Colombia. PLoS One 2020;15:e0235119. [PMID: 32574179 DOI: 10.1371/journal.pone.0235119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
34 Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. Plasmodium vivax in the Era of the Shrinking P. falciparum Map. Trends Parasitol 2020;36:560-70. [PMID: 32407682 DOI: 10.1016/j.pt.2020.03.009] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 27.3] [Reference Citation Analysis]
35 Oladeji OS, Oluyori AP, Bankole DT, Afolabi TY. Natural Products as Sources of Antimalarial Drugs: Ethnobotanical and Ethnopharmacological Studies. Scientifica (Cairo) 2020;2020:7076139. [PMID: 32455050 DOI: 10.1155/2020/7076139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
36 Islam MO, Palit P, Shawon J, Hasan MK, Mahfuz M, Ahmed T, Mondal D. An extensive computational approach to inhibit MSP-1 of P.vivax elucidates further horizon in the establishment next generation therapeutics against malaria.. [DOI: 10.1101/2020.05.02.073973] [Reference Citation Analysis]
37 Li JC, Lundsmith E. Empiric Treatment for Suspected Malaria in the United States: A Case Report. Cureus 2020;12:e7885. [PMID: 32489739 DOI: 10.7759/cureus.7885] [Reference Citation Analysis]
38 Im JH, Chung MH, Durey A, Kwon HY, Lee JS, Lee MJ, Baek JH. Splenic Infarction in Plasmodium vivax Infection in South Korea. Am J Trop Med Hyg 2019;101:803-5. [PMID: 31436158 DOI: 10.4269/ajtmh.19-0101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
39 Dini S, Douglas NM, Poespoprodjo JR, Kenangalem E, Sugiarto P, Plumb ID, Price RN, Simpson JA. The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study. BMC Med 2020;18:28. [PMID: 32075649 DOI: 10.1186/s12916-020-1497-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
40 Islam MO, Palit P, Shawon J, Hasan MK, Mahmud A, Mahfuz M, Ahmed T, Mondal D. Exploring novel therapeutic strategies against vivax malaria through an integrated computational investigation to inhibit the merozoite surface protein−1 of Plasmodium vivax. Informatics in Medicine Unlocked 2020;21:100471. [DOI: 10.1016/j.imu.2020.100471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Dayanand KK, Kishore P, Chandrashekar V, Achur RN, Ghosh SK, Kakkilaya SB, Kumari SN, Tiwari S, Boloor A, Devi R, Gowda DC. Malaria Severity in Mangaluru City in the Southwestern Coastal Region of India. Am J Trop Med Hyg 2019;100:275-9. [PMID: 30734693 DOI: 10.4269/ajtmh.18-0005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
42 Patriani D, Arguni E, Kenangalem E, Dini S, Sugiarto P, Hasanuddin A, Lampah DA, Douglas NM, Anstey NM, Simpson JA, Price RN, Poespoprodjo JR. Early and late mortality after malaria in young children in Papua, Indonesia. BMC Infect Dis 2019;19:922. [PMID: 31666012 DOI: 10.1186/s12879-019-4497-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
43 Baird JK. 8-Aminoquinoline Therapy for Latent Malaria. Clin Microbiol Rev 2019;32:e00011-19. [PMID: 31366609 DOI: 10.1128/CMR.00011-19] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 13.3] [Reference Citation Analysis]
44 Plewes K, Turner GDH, Dondorp AM. Pathophysiology, clinical presentation, and treatment of coma and acute kidney injury complicating falciparum malaria. Curr Opin Infect Dis 2018;31:69-77. [PMID: 29206655 DOI: 10.1097/QCO.0000000000000419] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
45 Baird JK. Tafenoquine for travelers' malaria: evidence, rationale and recommendations. J Travel Med 2018;25. [PMID: 30380095 DOI: 10.1093/jtm/tay110] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
46 Kho S, Minigo G, Andries B, Leonardo L, Prayoga P, Poespoprodjo JR, Kenangalem E, Price RN, Woodberry T, Anstey NM, Yeo TW. Circulating Neutrophil Extracellular Traps and Neutrophil Activation Are Increased in Proportion to Disease Severity in Human Malaria. J Infect Dis 2019;219:1994-2004. [PMID: 30452670 DOI: 10.1093/infdis/jiy661] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
47 Kenangalem E, Poespoprodjo JR, Douglas NM, Burdam FH, Gdeumana K, Chalfein F, Prayoga, Thio F, Devine A, Marfurt J, Waramori G, Yeung S, Noviyanti R, Penttinen P, Bangs MJ, Sugiarto P, Simpson JA, Soenarto Y, Anstey NM, Price RN. Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study. PLoS Med 2019;16:e1002815. [PMID: 31167228 DOI: 10.1371/journal.pmed.1002815] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
48 Dodean RA, Kancharla P, Li Y, Melendez V, Read L, Bane CE, Vesely B, Kreishman-Deitrick M, Black C, Li Q, Sciotti RJ, Olmeda R, Luong TL, Gaona H, Potter B, Sousa J, Marcsisin S, Caridha D, Xie L, Vuong C, Zeng Q, Zhang J, Zhang P, Lin H, Butler K, Roncal N, Gaynor-Ohnstad L, Leed SE, Nolan C, Huezo SJ, Rasmussen SA, Stephens MT, Tan JC, Cooper RA, Smilkstein MJ, Pou S, Winter RW, Riscoe MK, Kelly JX. Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials. J Med Chem 2019;62:3475-502. [PMID: 30852885 DOI: 10.1021/acs.jmedchem.8b01961] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
49 Kho S, Andries B, Poespoprodjo JR, Commons RJ, Shanti PAI, Kenangalem E, Douglas NM, Simpson JA, Sugiarto P, Anstey NM, Price RN. High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia. Clin Infect Dis 2019;68:51-60. [PMID: 29771281 DOI: 10.1093/cid/ciy403] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
50 Gowda DC, Wu X. Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria. Front Immunol 2018;9:3006. [PMID: 30619355 DOI: 10.3389/fimmu.2018.03006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 12.4] [Reference Citation Analysis]
51 Tamzali Y, Demeret S, Haddad E, Guillot H, Caumes E, Jauréguiberry S. Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework. Malar J 2018;17:387. [PMID: 30367650 DOI: 10.1186/s12936-018-2542-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
52 Kho S, Barber BE, Johar E, Andries B, Poespoprodjo JR, Kenangalem E, Piera KA, Ehmann A, Price RN, William T, Woodberry T, Foote S, Minigo G, Yeo TW, Grigg MJ, Anstey NM, McMorran BJ. Platelets kill circulating parasites of all major Plasmodium species in human malaria. Blood 2018;132:1332-44. [PMID: 30026183 DOI: 10.1182/blood-2018-05-849307] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 12.6] [Reference Citation Analysis]
53 Ourives SS, Borges QI, Dos Santos DSA, Melo ECM, de Souza RM, Damazo AS. Analysis of the lymphocyte cell population during malaria caused by Plasmodium vivax and its correlation with parasitaemia and thrombocytopaenia. Malar J 2018;17:303. [PMID: 30126413 DOI: 10.1186/s12936-018-2443-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
54 Baird JK, Louisa M, Noviyanti R, Ekawati L, Elyazar I, Subekti D, Chand K, Gayatri A, Instiaty, Soebianto S, Crenna-Darusallam C, Djoko D, Hasto BD, Meriyenes D, Wesche D, Nelwan EJ, Sutanto I, Sudoyo H, Setiabudy R. Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria. JAMA Netw Open 2018;1:e181449. [PMID: 30646129 DOI: 10.1001/jamanetworkopen.2018.1449] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 11.0] [Reference Citation Analysis]
55 Junqueira C, Barbosa CRR, Costa PAC, Teixeira-Carvalho A, Castro G, Sen Santara S, Barbosa RP, Dotiwala F, Pereira DB, Antonelli LR, Lieberman J, Gazzinelli RT. Cytotoxic CD8+ T cells recognize and kill Plasmodium vivax-infected reticulocytes. Nat Med 2018;24:1330-6. [PMID: 30038217 DOI: 10.1038/s41591-018-0117-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
56 Ohrt C, Ngo TD, Nguyen TQ. Challenges in the Control and Elimination of Plasmodium vivax Malaria. Towards Malaria Elimination - A Leap Forward 2018. [DOI: 10.5772/intechopen.77082] [Reference Citation Analysis]
57 Mourão LC, Baptista RP, de Almeida ZB, Grynberg P, Pucci MM, Castro-Gomes T, Fontes CJF, Rathore S, Sharma YD, da Silva-Pereira RA, Bemquerer MP, Braga ÉM. Anti-band 3 and anti-spectrin antibodies are increased in Plasmodium vivax infection and are associated with anemia. Sci Rep 2018;8:8762. [PMID: 29884876 DOI: 10.1038/s41598-018-27109-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
58 Baird JK. Therapeutic principles of primaquine against relapse ofPlasmodium vivaxmalaria. IOP Conf Ser : Earth Environ Sci 2018;125:012098. [DOI: 10.1088/1755-1315/125/1/012098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
59 Coban C, Lee MSJ, Ishii KJ. Tissue-specific immunopathology during malaria infection. Nat Rev Immunol 2018;18:266-78. [PMID: 29332936 DOI: 10.1038/nri.2017.138] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
60 Milner DA Jr. Malaria Pathogenesis. Cold Spring Harb Perspect Med 2018;8:a025569. [PMID: 28533315 DOI: 10.1101/cshperspect.a025569] [Cited by in Crossref: 67] [Cited by in F6Publishing: 76] [Article Influence: 13.4] [Reference Citation Analysis]
61 Chew CH, Lim YAL, Chua KH. Heterologous expression of Plasmodium vivax apical membrane antigen 1 (PvAMA1) for binding peptide selection. PeerJ 2017;5:e3794. [PMID: 28929019 DOI: 10.7717/peerj.3794] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
62 J Joyner C, Consortium TM, Wood JS, Moreno A, Garcia A, Galinski MR. Case Report: Severe and Complicated Cynomolgi Malaria in a Rhesus Macaque Resulted in Similar Histopathological Changes as Those Seen in Human Malaria. Am J Trop Med Hyg 2017;97:548-55. [PMID: 28829738 DOI: 10.4269/ajtmh.16-0742] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
63 Gardinassi LG, Cordy RJ, Lacerda MVG, Salinas JL, Monteiro WM, Melo GC, Siqueira AM, Val FF, Tran V, Jones DP, Galinski MR, Li S. Metabolome-wide association study of peripheral parasitemia in Plasmodium vivax malaria. Int J Med Microbiol 2017;307:533-41. [PMID: 28927849 DOI: 10.1016/j.ijmm.2017.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
64 Adams JH, Mueller I. The Biology of Plasmodium vivax. Cold Spring Harb Perspect Med 2017;7:a025585. [PMID: 28490540 DOI: 10.1101/cshperspect.a025585] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 7.8] [Reference Citation Analysis]
65 Douglas NM, Poespoprodjo JR, Patriani D, Malloy MJ, Kenangalem E, Sugiarto P, Simpson JA, Soenarto Y, Anstey NM, Price RN. Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study. PLoS Med 2017;14:e1002379. [PMID: 28850568 DOI: 10.1371/journal.pmed.1002379] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 10.0] [Reference Citation Analysis]
66 Val F, Machado K, Barbosa L, Salinas JL, Siqueira AM, Costa Alecrim MG, Portillo HD, Bassat Q, Monteiro WM, Guimarães Lacerda MV. Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis. Am J Trop Med Hyg 2017;97:733-43. [PMID: 28722625 DOI: 10.4269/ajtmh.17-0131] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
67 Balabaskaran Nina P, Mohanty AK, Ballav S, Vernekar S, Bhinge S, D'souza M, Walke J, Manoharan SK, Mascarenhas A, Gomes E, Chery L, Valecha N, Kumar A, Rathod PK. Dynamics of Plasmodium vivax sporogony in wild Anopheles stephensi in a malaria-endemic region of Western India. Malar J 2017;16:284. [PMID: 28693607 DOI: 10.1186/s12936-017-1931-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
68 Kahn M, LaRue N, Zhu C, Pal S, Mo JS, Barrett LK, Hewitt SN, Dumais M, Hemmington S, Walker A, Joynson J, Leader BT, Van Voorhis WC, Domingo GJ. Recombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiency. PLoS One 2017;12:e0177885. [PMID: 28552983 DOI: 10.1371/journal.pone.0177885] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
69 Woodberry T, Loughland JR, Minigo G, Burel JG, Amante FH, Piera KA, McNeil Y, Yeo TW, Good MF, Doolan DL, Engwerda CR, McCarthy JS, Anstey NM. Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c+ Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell Activation. Infect Immun 2017;85:e00986-16. [PMID: 28320838 DOI: 10.1128/IAI.00986-16] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
70 Ghimire P, Singh N, Ortega L, Rijal KR, Adhikari B, Thakur GD, Marasini B. Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal. Malar J 2017;16:214. [PMID: 28535765 DOI: 10.1186/s12936-017-1864-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
71 Ding XC, Ade MP, Baird JK, Cheng Q, Cunningham J, Dhorda M, Drakeley C, Felger I, Gamboa D, Harbers M, Herrera S, Lucchi N, Mayor A, Mueller I, Sattabongkot J, Ratsimbason A, Richards J, Tanner M, González IJ. Defining the next generation of Plasmodium vivax diagnostic tests for control and elimination: Target product profiles. PLoS Negl Trop Dis 2017;11:e0005516. [PMID: 28369085 DOI: 10.1371/journal.pntd.0005516] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
72 Baird JK. Management of Plasmodium vivax risk and illness in travelers. Trop Dis Travel Med Vaccines 2017;3:7. [PMID: 28883977 DOI: 10.1186/s40794-017-0049-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
73 Russo G, Faggioni G, Paganotti GM, Djeunang Dongho GB, Pomponi A, De Santis R, Tebano G, Mbida M, Sanou Sobze M, Vullo V, Rezza G, Lista FR. Molecular evidence of Plasmodium vivax infection in Duffy negative symptomatic individuals from Dschang, West Cameroon. Malar J 2017;16:74. [PMID: 28196496 DOI: 10.1186/s12936-017-1722-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
74 F. Abiola A. Risk Factors for Kidney Disease in Disadvantaged Populations—Communicable Diseases, Environmental Factors, and Pollutants. Chronic Kidney Disease in Disadvantaged Populations 2017. [DOI: 10.1016/b978-0-12-804311-0.00020-0] [Reference Citation Analysis]
75 Mueller I, Bassat Q, Lacerda MVG, del Portillo HA. Plasmodium vivax. Advances in Malaria Research 2016. [DOI: 10.1002/9781118493816.ch20] [Reference Citation Analysis]
76 Gonçalves BP, Fried M, Duffy PE. Malaria pathogenesis. Advances in Malaria Research 2016. [DOI: 10.1002/9781118493816.ch16] [Reference Citation Analysis]
77 Baird JK. Asia-Pacific malaria is singular, pervasive, diverse and invisible. Int J Parasitol 2017;47:371-7. [PMID: 27836630 DOI: 10.1016/j.ijpara.2016.06.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
78 Olliaro PL, Barnwell JW, Barry A, Mendis K, Mueller I, Reeder JC, Shanks GD, Snounou G, Wongsrichanalai C. Implications of Plasmodium vivax Biology for Control, Elimination, and Research. Am J Trop Med Hyg 2016;95:4-14. [PMID: 27799636 DOI: 10.4269/ajtmh.16-0160] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
79 Pava Z, Burdam FH, Handayuni I, Trianty L, Utami RA, Tirta YK, Kenangalem E, Lampah D, Kusuma A, Wirjanata G, Kho S, Simpson JA, Auburn S, Douglas NM, Noviyanti R, Anstey NM, Poespoprodjo JR, Marfurt J, Price RN. Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia. PLoS One 2016;11:e0165340. [PMID: 27788243 DOI: 10.1371/journal.pone.0165340] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
80 Baird JK, Valecha N, Duparc S, White NJ, Price RN. Diagnosis and Treatment of Plasmodium vivax Malaria. Am J Trop Med Hyg 2016;95:35-51. [PMID: 27708191 DOI: 10.4269/ajtmh.16-0171] [Cited by in Crossref: 48] [Cited by in F6Publishing: 55] [Article Influence: 6.9] [Reference Citation Analysis]
81 Rajahram GS, Barber BE, William T, Grigg MJ, Menon J, Yeo TW, Anstey NM. Falling Plasmodium knowlesi Malaria Death Rate among Adults despite Rising Incidence, Sabah, Malaysia, 2010-2014. Emerg Infect Dis 2016;22:41-8. [PMID: 26690736 DOI: 10.3201/eid2201.151305] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
82 Barber BE, William T, Grigg MJ, Piera KA, Chen Y, Wang H, Weinberg JB, Yeo TW, Anstey NM. Nitric Oxide-Dependent Endothelial Dysfunction and Reduced Arginine Bioavailability in Plasmodium vivax Malaria but No Greater Increase in Intravascular Hemolysis in Severe Disease. J Infect Dis 2016;214:1557-64. [PMID: 27630198 DOI: 10.1093/infdis/jiw427] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
83 Joyner C, Moreno A, Meyer EV, Cabrera-Mora M, Kissinger JC, Barnwell JW, Galinski MR; MaHPIC Consortium. Plasmodium cynomolgi infections in rhesus macaques display clinical and parasitological features pertinent to modelling vivax malaria pathology and relapse infections. Malar J 2016;15:451. [PMID: 27590312 DOI: 10.1186/s12936-016-1480-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
84 Demissie Y, Ketema T. Complicated malaria symptoms associated with Plasmodium vivax among patients visiting health facilities in Mendi town, Northwest Ethiopia. BMC Infect Dis 2016;16:436. [PMID: 27549864 DOI: 10.1186/s12879-016-1780-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
85 Boyle MJ, Reiling L, Osier FH, Fowkes FJ. Recent insights into humoral immunity targeting Plasmodium falciparum and Plasmodium vivax malaria. Int J Parasitol 2017;47:99-104. [PMID: 27451359 DOI: 10.1016/j.ijpara.2016.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
86 Howes RE, Battle KE, Mendis KN, Smith DL, Cibulskis RE, Baird JK, Hay SI. Global Epidemiology of Plasmodium vivax. Am J Trop Med Hyg 2016;95:15-34. [PMID: 27402513 DOI: 10.4269/ajtmh.16-0141] [Cited by in Crossref: 228] [Cited by in F6Publishing: 237] [Article Influence: 32.6] [Reference Citation Analysis]
87 Vallejo AF, Rubiano K, Amado A, Krystosik AR, Herrera S, Arévalo-Herrera M. Optimization of a Membrane Feeding Assay for Plasmodium vivax Infection in Anopheles albimanus. PLoS Negl Trop Dis 2016;10:e0004807. [PMID: 27355210 DOI: 10.1371/journal.pntd.0004807] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
88 Niederhauser C, Gottschalk J, Tinguely C. Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland. Transfus Med Hemother 2016;43:169-76. [PMID: 27403088 DOI: 10.1159/000446218] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
89 Monteiro WM, Alexandre MA, Siqueira A, Melo G, Romero GA, d'Ávila E, Benzecry SG, Leite HP, Lacerda MV. Could Plasmodium vivax malaria trigger malnutrition? Revisiting the Bradford Hill criteria to assess a causal relationship between two neglected problems. Rev Soc Bras Med Trop 2016;49:274-8. [PMID: 27384822 DOI: 10.1590/0037-8682-0397-2015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
90 Halsey ES, Baldeviano GC, Edgel KA, Vilcarromero S, Sihuincha M, Lescano AG. Symptoms and Immune Markers in Plasmodium/Dengue Virus Co-infection Compared with Mono-infection with Either in Peru. PLoS Negl Trop Dis 2016;10:e0004646. [PMID: 27128316 DOI: 10.1371/journal.pntd.0004646] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
91 Kim JY, Goo YK, Zo YG, Ji SY, Trimarsanto H, To S, Clark TG, Price RN, Auburn S. Further Evidence of Increasing Diversity of Plasmodium vivax in the Republic of Korea in Recent Years. PLoS One 2016;11:e0151514. [PMID: 26990869 DOI: 10.1371/journal.pone.0151514] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
92 Baird K. Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria. Pathog Glob Health 2015;109:93-106. [PMID: 25943156 DOI: 10.1179/2047773215Y.0000000016] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
93 Satyagraha AW, Sadhewa A, Elvira R, Elyazar I, Feriandika D, Antonjaya U, Oyong D, Subekti D, Rozi IE, Domingo GJ, Harahap AR, Baird JK. Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia. PLoS Negl Trop Dis 2016;10:e0004457. [PMID: 26894297 DOI: 10.1371/journal.pntd.0004457] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
94 Britton S, Cheng Q, Grigg MJ, Poole CB, Pasay C, William T, Fornace K, Anstey NM, Sutherland CJ, Drakeley C, McCarthy JS. Sensitive Detection of Plasmodium vivax Using a High-Throughput, Colourimetric Loop Mediated Isothermal Amplification (HtLAMP) Platform: A Potential Novel Tool for Malaria Elimination. PLoS Negl Trop Dis 2016;10:e0004443. [PMID: 26870958 DOI: 10.1371/journal.pntd.0004443] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
95 Zhu L, Mok S, Imwong M, Jaidee A, Russell B, Nosten F, Day NP, White NJ, Preiser PR, Bozdech Z. New insights into the Plasmodium vivax transcriptome using RNA-Seq. Sci Rep 2016;6:20498. [PMID: 26858037 DOI: 10.1038/srep20498] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 7.6] [Reference Citation Analysis]
96 Lin Chua CL, Ataíde R, Umbers AJ, Boeuf P. Pathogenesis of Malarial Parasites in Humans. Human Emerging and Re‐emerging Infections 2015. [DOI: 10.1002/9781118644843.ch21] [Reference Citation Analysis]
97 Hostetler JB, Sharma S, Bartholdson SJ, Wright GJ, Fairhurst RM, Rayner JC. A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions. PLoS Negl Trop Dis 2015;9:e0004264. [PMID: 26701602 DOI: 10.1371/journal.pntd.0004264] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
98 Howes RE, Reiner RC Jr, Battle KE, Longbottom J, Mappin B, Ordanovich D, Tatem AJ, Drakeley C, Gething PW, Zimmerman PA, Smith DL, Hay SI. Plasmodium vivax Transmission in Africa. PLoS Negl Trop Dis 2015;9:e0004222. [PMID: 26587988 DOI: 10.1371/journal.pntd.0004222] [Cited by in Crossref: 81] [Cited by in F6Publishing: 83] [Article Influence: 10.1] [Reference Citation Analysis]
99 Aung NM, Kaung M, Kyi TT, Kyaw MP, Min M, Htet ZW, Anstey NM, Kyi MM, Hanson J. The Safety of a Conservative Fluid Replacement Strategy in Adults Hospitalised with Malaria. PLoS One 2015;10:e0143062. [PMID: 26581060 DOI: 10.1371/journal.pone.0143062] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
100 Hirako IC, Gallego-Marin C, Ataide MA, Andrade WA, Gravina H, Rocha BC, de Oliveira RB, Pereira DB, Vinetz J, Diamond B, Ram S, Golenbock DT, Gazzinelli RT. DNA-Containing Immunocomplexes Promote Inflammasome Assembly and Release of Pyrogenic Cytokines by CD14+ CD16+ CD64high CD32low Inflammatory Monocytes from Malaria Patients. mBio 2015;6:e01605-15. [PMID: 26578679 DOI: 10.1128/mBio.01605-15] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
101 Howard N, Enayatullah S, Mohammad N, Mayan I, Shamszai Z, Rowland M, Leslie T. Towards a strategy for malaria in pregnancy in Afghanistan: analysis of clinical realities and women's perceptions of malaria and anaemia. Malar J 2015;14:431. [PMID: 26537247 DOI: 10.1186/s12936-015-0964-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
102 Pava Z, Handayuni I, Wirjanata G, To S, Trianty L, Noviyanti R, Poespoprodjo JR, Auburn S, Price RN, Marfurt J. Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility. Antimicrob Agents Chemother 2016;60:361-7. [PMID: 26525783 DOI: 10.1128/AAC.02207-15] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
103 de Sousa TN, Kano FS, de Brito CF, Carvalho LH. The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian Amazon. Mem Inst Oswaldo Cruz 2014;109:608-17. [PMID: 25185002 DOI: 10.1590/0074-0276130592] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
104 Ferreira Ed, Alexandre MA, Salinas JL, de Siqueira AM, Benzecry SG, de Lacerda MV, Monteiro WM. Association between anthropometry-based nutritional status and malaria: a systematic review of observational studies. Malar J 2015;14:346. [PMID: 26377094 DOI: 10.1186/s12936-015-0870-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
105 Tanner M, Greenwood B, Whitty CJ, Ansah EK, Price RN, Dondorp AM, von Seidlein L, Baird JK, Beeson JG, Fowkes FJ, Hemingway J, Marsh K, Osier F. Malaria eradication and elimination: views on how to translate a vision into reality. BMC Med 2015;13:167. [PMID: 26208740 DOI: 10.1186/s12916-015-0384-6] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 11.1] [Reference Citation Analysis]
106 Kho S, Marfurt J, Noviyanti R, Kusuma A, Piera KA, Burdam FH, Kenangalem E, Lampah DA, Engwerda CR, Poespoprodjo JR, Price RN, Anstey NM, Minigo G, Woodberry T. Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection. Infect Immun 2015;83:3224-32. [PMID: 26034211 DOI: 10.1128/IAI.00226-15] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
107 Campo B, Vandal O, Wesche DL, Burrows JN. Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax. Pathog Glob Health 2015;109:107-22. [PMID: 25891812 DOI: 10.1179/2047773215Y.0000000013] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 9.0] [Reference Citation Analysis]
108 Mikolajczak SA, Vaughan AM, Kangwanrangsan N, Roobsoong W, Fishbaugher M, Yimamnuaychok N, Rezakhani N, Lakshmanan V, Singh N, Kaushansky A, Camargo N, Baldwin M, Lindner SE, Adams JH, Sattabongkot J, Kappe SH. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe 2015;17:526-35. [PMID: 25800544 DOI: 10.1016/j.chom.2015.02.011] [Cited by in Crossref: 148] [Cited by in F6Publishing: 152] [Article Influence: 18.5] [Reference Citation Analysis]
109 McLean AR, Ataide R, Simpson JA, Beeson JG, Fowkes FJ. Malaria and immunity during pregnancy and postpartum: a tale of two species. Parasitology 2015;142:999-1015. [PMID: 25731914 DOI: 10.1017/S0031182015000074] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
110 Kaung M, Kyi TT, Aung NM, Kyaw MP, Min M, Htet ZW, Anstey NM, Kyi MM, Hanson J. The prognostic utility of bedside assessment of adults hospitalized with malaria in Myanmar: a retrospective analysis. Malar J 2015;14:63. [PMID: 25881290 DOI: 10.1186/s12936-015-0549-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
111 Cunnington AJ. The importance of pathogen load. PLoS Pathog 2015;11:e1004563. [PMID: 25569282 DOI: 10.1371/journal.ppat.1004563] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
112 Barber BE, William T, Grigg MJ, Parameswaran U, Piera KA, Price RN, Yeo TW, Anstey NM. Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria. PLoS Pathog 2015;11:e1004558. [PMID: 25569250 DOI: 10.1371/journal.ppat.1004558] [Cited by in Crossref: 104] [Cited by in F6Publishing: 108] [Article Influence: 13.0] [Reference Citation Analysis]
113 Ourives S, Santos DD, Alem L, Rios-santo F, Fontes C, Damazo A. Analysis of Parasitological and Haematological Parameters and of CD4+ and CD8+ Cell Number in Patients with Plasmodium vivax Malaria. Research J of Parasitology 2015;10:1-14. [DOI: 10.3923/jp.2015.1.14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
114 Kingston H, Turner G, Day N. Lung Involvement in Malaria. Encyclopedia of Malaria 2015. [DOI: 10.1007/978-1-4614-8757-9_124-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
115 Ingram RJ, Crenna-Darusallam C, Soebianto S, Noviyanti R, Baird JK. The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea. Malar J 2014;13:488. [PMID: 25495607 DOI: 10.1186/1475-2875-13-488] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
116 Hanson J, Anstey NM, Bihari D, White NJ, Day NP, Dondorp AM. The fluid management of adults with severe malaria. Crit Care 2014;18:642. [PMID: 25629462 DOI: 10.1186/s13054-014-0642-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
117 Douglas NM, Pontororing GJ, Lampah DA, Yeo TW, Kenangalem E, Poespoprodjo JR, Ralph AP, Bangs MJ, Sugiarto P, Anstey NM, Price RN. Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia. BMC Med 2014;12:217. [PMID: 25406857 DOI: 10.1186/s12916-014-0217-z] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 7.4] [Reference Citation Analysis]
118 Totino PR, Magalhães Ad, Alves EB, Costa MR, de Lacerda MV, Daniel-Ribeiro CT, Ferreira-da-Cruz Mde F. Plasmodium falciparum, but not P. vivax, can induce erythrocytic apoptosis. Parasit Vectors 2014;7:484. [PMID: 25325923 DOI: 10.1186/s13071-014-0484-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
119 Gazzinelli RT, Kalantari P, Fitzgerald KA, Golenbock DT. Innate sensing of malaria parasites. Nat Rev Immunol 2014;14:744-57. [PMID: 25324127 DOI: 10.1038/nri3742] [Cited by in Crossref: 194] [Cited by in F6Publishing: 194] [Article Influence: 21.6] [Reference Citation Analysis]
120 Hwang JH, Lee CS. Malaria-induced splenic infarction. Am J Trop Med Hyg 2014;91:1094-100. [PMID: 25294615 DOI: 10.4269/ajtmh.14-0190] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
121 Gomes LT, Alves-Junior ER, Rodrigues-Jesus C, Nery AF, Gasquez-Martin TO, Fontes CJ. Angiopoietin-2 and angiopoietin-2/angiopoietin-1 ratio as indicators of potential severity of Plasmodium vivax malaria in patients with thrombocytopenia. PLoS One 2014;9:e109246. [PMID: 25275496 DOI: 10.1371/journal.pone.0109246] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
122 Baird JK, Dewi M, Subekti D, Elyazar I, Satyagraha AW. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells. Transl Res 2015;165:677-88. [PMID: 25312015 DOI: 10.1016/j.trsl.2014.09.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
123 Cutts JC, Powell R, Agius PA, Beeson JG, Simpson JA, Fowkes FJ. Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis. BMC Med 2014;12:150. [PMID: 25199532 DOI: 10.1186/s12916-014-0150-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 7.2] [Reference Citation Analysis]
124 Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis 2014;14:982-91. [PMID: 25213732 DOI: 10.1016/S1473-3099(14)70855-2] [Cited by in Crossref: 238] [Cited by in F6Publishing: 254] [Article Influence: 26.4] [Reference Citation Analysis]
125 Siqueira AM, Cavalcante JA, Vítor-Silva S, Reyes-Lecca RC, Alencar AC, Monteiro WM, Alexandre MA, Mourão MP, Guinovart C, Bassat Q, Alecrim Md, Lacerda MV. Influence of age on the haemoglobin concentration of malaria-infected patients in a reference centre in the Brazilian Amazon. Mem Inst Oswaldo Cruz 2014;109:569-76. [PMID: 25141283 DOI: 10.1590/0074-0276140132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
126 McGready R, Wongsaen K, Chu CS, Tun NW, Chotivanich K, White NJ, Nosten F. Uncomplicated Plasmodium vivax malaria in pregnancy associated with mortality from acute respiratory distress syndrome. Malar J 2014;13:191. [PMID: 24886559 DOI: 10.1186/1475-2875-13-191] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
127 Black BO, Bignall JK, Gupta M. It is All in the Smear. Infectious Diseases in Clinical Practice 2014;22:177-179. [DOI: 10.1097/ipc.0b013e31828f4d99] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
128 Baird JK. Pernicious and threatening Plasmodium vivax as reality. Am J Trop Med Hyg 2014;91:1-2. [PMID: 24752684 DOI: 10.4269/ajtmh.14-0111] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
129 Shakri AR, Chitnis CE. Progress towards development of a vaccine forPlasmodium vivaxmalaria. Malaria Vaccine Development: Over 40 Years of Trials and Tribulations 2014. [DOI: 10.2217/fmeb2013.13.213] [Reference Citation Analysis]
130 Ataide MA, Andrade WA, Zamboni DS, Wang D, Souza Mdo C, Franklin BS, Elian S, Martins FS, Pereira D, Reed G, Fitzgerald KA, Golenbock DT, Gazzinelli RT. Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection. PLoS Pathog 2014;10:e1003885. [PMID: 24453977 DOI: 10.1371/journal.ppat.1003885] [Cited by in Crossref: 102] [Cited by in F6Publishing: 106] [Article Influence: 11.3] [Reference Citation Analysis]
131 Duffy PE, Acharya P, Oleinikov AV. Cytoadherence. Encyclopedia of Malaria 2014. [DOI: 10.1007/978-1-4614-8757-9_39-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
132 Baird JK, Satyagraha AW, Bancone G. Glucose-6-Phosphate Dehydrogenase Deficiency and Primaquine Hemolytic Toxicity. Encyclopedia of Malaria 2014. [DOI: 10.1007/978-1-4614-8757-9_102-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
133 Schmidt M, Geilenkeuser WJ, Sireis W, Seifried E, Hourfar K. Emerging Pathogens - How Safe is Blood? Transfus Med Hemother 2014;41:10-7. [PMID: 24659943 DOI: 10.1159/000358017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
134 Zeeman AM, van Amsterdam SM, McNamara CW, Voorberg-van der Wel A, Klooster EJ, van den Berg A, Remarque EJ, Plouffe DM, van Gemert GJ, Luty A, Sauerwein R, Gagaring K, Borboa R, Chen Z, Kuhen K, Glynne RJ, Chatterjee AK, Nagle A, Roland J, Winzeler EA, Leroy D, Campo B, Diagana TT, Yeung BK, Thomas AW, Kocken CH. KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro. Antimicrob Agents Chemother 2014;58:1586-95. [PMID: 24366744 DOI: 10.1128/AAC.01927-13] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 5.7] [Reference Citation Analysis]
135 Borges QI, Fontes CJ, Damazo AS. Analysis of lymphocytes in patients with Plasmodium vivax malaria and its relation to the annexin-A1 and IL-10. Malar J 2013;12:455. [PMID: 24359168 DOI: 10.1186/1475-2875-12-455] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
136 Douglas NM, Lampah DA, Kenangalem E, Simpson JA, Poespoprodjo JR, Sugiarto P, Anstey NM, Price RN. Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study. PLoS Med 2013;10:e1001575; discussion e1001575. [PMID: 24358031 DOI: 10.1371/journal.pmed.1001575] [Cited by in Crossref: 97] [Cited by in F6Publishing: 97] [Article Influence: 9.7] [Reference Citation Analysis]
137 Cunnington AJ, Riley EM, Walther M. Stuck in a rut? Reconsidering the role of parasite sequestration in severe malaria syndromes. Trends Parasitol 2013;29:585-92. [PMID: 24210256 DOI: 10.1016/j.pt.2013.10.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
138 Martins Braga É, Carvalho-tavares J. Malaria. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2013;5:1-187. [DOI: 10.4199/c00091ed1v01y201309isp045] [Reference Citation Analysis]
139 Bhattacharya SK, Sur D, Dutta S, Kanungo S, Ochiai RL, Kim DR, Anstey NM, von Seidlein L, Deen J. Vivax malaria and bacteraemia: a prospective study in Kolkata, India. Malar J 2013;12:176. [PMID: 23721247 DOI: 10.1186/1475-2875-12-176] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
140 Cunnington AJ, Bretscher MT, Nogaro SI, Riley EM, Walther M. Comparison of parasite sequestration in uncomplicated and severe childhood Plasmodium falciparum malaria. J Infect 2013;67:220-30. [PMID: 23623771 DOI: 10.1016/j.jinf.2013.04.013] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
141 Barber BE, William T, Grigg MJ, Yeo TW, Anstey NM. Limitations of microscopy to differentiate Plasmodium species in a region co-endemic for Plasmodium falciparum, Plasmodium vivax and Plasmodium knowlesi. Malar J 2013;12:8. [PMID: 23294844 DOI: 10.1186/1475-2875-12-8] [Cited by in Crossref: 81] [Cited by in F6Publishing: 86] [Article Influence: 8.1] [Reference Citation Analysis]